Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Biotech
Pfizer maps out $865M Cartography discovery deal
Cartography will use its drug discovery platforms—coded Atlas and Summit—to find and validate tumor-selective antigens that Pfizer can then pick up.
Gabrielle Masson
Jan 6, 2026 7:30am
Pfizer RNA leader runs to Replicate—Chutes & Ladders
Dec 19, 2025 8:30am
Athira inks deal to power ex-Pfizer asset toward phase 3 data
Dec 18, 2025 10:56am
Pfizer, Sanofi round out '25 with separate autoimmune deals
Dec 15, 2025 11:06am
Pfizer signs $1.9B pact for Fosun unit's GLP-1 drug
Dec 9, 2025 8:00am
Pfizer Ventures gets behind Chinese biotech's $100M series A
Dec 5, 2025 4:20am